Search
for
Sort by
Research 91–120 of 1000+
- Gastric cancer; actualities and perspectives of early diagnosis and targeted therapy
- Antitumor Activities of the Typhonium flagelliforme Extract Combined with Natural Interferons of Canine and Feline in Mice with DMBA Induced Skin Tumors
- Diabetogenic potential of dexamethasone and effect Annona muricata methanolic bark extract as post-exposure therapy in albino rats
- Necrolytic Migratory Erythema in a Cat with Glucagonoma Syndrome
- Malarone® induced pancreatitis and alopecia in a dog: a case report
- Lignans and Neolignans: Plant secondary metabolites as a reservoir of biologically active substances
- The roles of Wnt/β‐catenin pathway in tissue development and regenerative medicine
- Exploring the Drug Repurposing Versatility of Valproic Acid as a Multifunctional Regulator of Innate and Adaptive Immune Cells
- Targeting Wnt Signaling for Gastrointestinal Cancer Therapy: Present and Evolving Views
- Emerging Roles for Ion Channels in Ovarian Cancer: Pathomechanisms and Pharmacological Treatment
- Cellular heterogeneity and microenvironmental control of skin cancer
- High-confidence cancer patient stratification through multiomics investigation of DNA repair disorders
- Beyond DNA-targeting in Cancer Chemotherapy. Emerging Frontiers - A Review
- Proteolysis‐targeting chimeras in cancer therapy: Targeted protein degradation for next‐generation treatment
- Diabetes Mellitus and Prostate Cancer Risk—A Systematic Review and Meta-Analysis
- The exploration of mitochondrial‐related features helps to reveal the prognosis and immunotherapy methods of colorectal cancer
- Modulating the stem cell niche for tissue regeneration
- Stretching the limits: from homeostasis to stem cell plasticity in wound healing and cancer
- TGFβ and cancer metastasis: an inflammation link
- Polycystic Ovarian Syndrome: Long-Term Health Consequences
- Repurposing Kir6/SUR2 Channel Activator Minoxidil to Arrests Growth of Gynecologic Cancers
- Clinical Management of Prostate Cancer in High-Risk Genetic Mutation Carriers
- Computational derivation of a molecular framework for hair follicle biology from disease genes
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- Cancer-Related Alopecia Risk and Treatment
- Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organization for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI)
- Newly Developed Targeted Therapies Against the Androgen Receptor in Triple-Negative Breast Cancer: A Review
- PROTACs: A novel strategy for cancer drug discovery and development
- Pre‐clinical evidences for the efficacy of tryptanthrin as a potent suppressor of skin cancer
- 12-Chloracetyl-PPD, a novel dammarane derivative, shows anti-cancer activity via delay the progression of cell cycle G2/M phase and reactive oxygen species-mediate cell apoptosis